| Aug 14 |
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
|
| Aug 12 |
ImmunityBio (IBRX) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 12 |
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
|
| Jul 31 |
Why Is Absci Corporation (ABSI) Among the Best Micro Cap Stocks Right Now?
|
| Jul 28 |
Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
|
| Jul 12 |
Entrada Therapeutics (TRDA) Moves 10.4% Higher: Will This Strength Last?
|
| Jul 10 |
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
|
| Jul 3 |
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
| Jul 3 |
Morgan Stanley starts Absci at overweight, cites AI theme
|
| Jun 29 |
Institutional investors own a significant stake of 46% in Absci Corporation (NASDAQ:ABSI)
|
